Barzolvolimab
Modify Date: 2024-04-09 18:12:46
Barzolvolimab structure
|
Common Name | Barzolvolimab | ||
|---|---|---|---|---|
| CAS Number | 2438203-51-9 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BarzolvolimabBarzolvolimab (CDX 0159) is a humanized anti-KIT IgG1 monoclonal antibody. Barzolvolimab specificity and potently inhibits KIT activation by SCF. Barzolvolimab can reduce skin mast cells and disease activity in chronic inducible urticaria[1]. |
| Name | Barzolvolimab |
|---|
| Description | Barzolvolimab (CDX 0159) is a humanized anti-KIT IgG1 monoclonal antibody. Barzolvolimab specificity and potently inhibits KIT activation by SCF. Barzolvolimab can reduce skin mast cells and disease activity in chronic inducible urticaria[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Barzolvolimab 以高特异性和亚纳摩尔亲和力结合 KIT 的细胞外结构域，并变构抑制干细胞因子 (SCF) 的激活[1]。 |
| References |
| No Any Chemical & Physical Properties |